137 related articles for article (PubMed ID: 12762141)
41. [Heart transplantation and the subsequent treatment of AL amyloidosis].
Adam Z; Krejčí J; Krejčí M; Němec P; Spinarová L; Zampachová V; Cermáková Z; Pika T; Pour L; Kořístek Z; Tomíška M; Szturz P; Král Z; Mayer J
Vnitr Lek; 2013 Feb; 59(2):136-47. PubMed ID: 23461404
[TBL] [Abstract][Full Text] [Related]
42. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
Comenzo RL
Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
[TBL] [Abstract][Full Text] [Related]
43. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
44. [Autologous stem cell transplantation in the treatment of primary systemic amyloidosis].
Gil L; Komarnicki M
Pol Merkur Lekarski; 2009 Sep; 27(159):181-4. PubMed ID: 19827724
[TBL] [Abstract][Full Text] [Related]
45. No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.
Zeier M; Perz J; Linke RP; Donini U; Waldherr R; Andrassy K; Ho AD; Goldschmidt H
Nephrol Dial Transplant; 2003 Dec; 18(12):2644-7. PubMed ID: 14605290
[TBL] [Abstract][Full Text] [Related]
46. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.
Skinner M; Sanchorawala V; Seldin DC; Dember LM; Falk RH; Berk JL; Anderson JJ; O'Hara C; Finn KT; Libbey CA; Wiesman J; Quillen K; Swan N; Wright DG
Ann Intern Med; 2004 Jan; 140(2):85-93. PubMed ID: 14734330
[TBL] [Abstract][Full Text] [Related]
47. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
Amyloid; 2009 Dec; 16(4):243-5. PubMed ID: 19922338
[TBL] [Abstract][Full Text] [Related]
48. Primary Localized Amyloidosis of the Intestine: A Pathologist Viewpoint.
Alshehri SA; Hussein MRA
Gastroenterology Res; 2020 Aug; 13(4):129-137. PubMed ID: 32864023
[TBL] [Abstract][Full Text] [Related]
49. [Polyneuropathy is an early finding in primary systemic amyloidosis].
Romi F; Vedeler C; Tysnes OB; Mørk S; Aarli JA
Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1291-3. PubMed ID: 10868089
[TBL] [Abstract][Full Text] [Related]
50. [Therapy options in systemic AL-amyloidosis with renal involvement].
Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B
Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911
[TBL] [Abstract][Full Text] [Related]
51. AL Amyloidoma of the Skin/Subcutis: Cutaneous Amyloidosis, Plasma Cell Dyscrasia or a Manifestation of Primary Cutaneous Marginal Zone Lymphoma?
Walsh NM; Lano IM; Green P; Gallant C; Pasternak S; Ly TY; Requena L; Kutzner H; Chott A; Cerroni L
Am J Surg Pathol; 2017 Aug; 41(8):1069-1076. PubMed ID: 28505007
[TBL] [Abstract][Full Text] [Related]
52. Focal globular amyloidosis of the colon. An exceptional diagnosis.
Martín-Arranz E; Pascual-Turrión JM; Martín-Arranz MD; Burgos E; Froilán-Torres C; Adán-Merino L; Lorenzo A; Segura-Cabral JM
Rev Esp Enferm Dig; 2010 Sep; 102(9):555-6. PubMed ID: 20883073
[No Abstract] [Full Text] [Related]
53. Neurologic complications of primary systemic amyloidosis.
Kelly JJ
Rev Neurol Dis; 2006; 3(4):173-81. PubMed ID: 17224900
[TBL] [Abstract][Full Text] [Related]
54. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
55. Primary systemic amyloidosis with delayed progression to multiple myeloma.
Rajkumar SV; Gertz MA; Kyle RA
Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
[TBL] [Abstract][Full Text] [Related]
56. Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point.
Akay OM; Sahin G; Kabukcuoglu S; Yalcin AU; Gulbas Z
Clin Nephrol; 2008 Apr; 69(4):294-7. PubMed ID: 18397705
[TBL] [Abstract][Full Text] [Related]
57. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
Amyloid; 2009; 16(3):183-5. PubMed ID: 19590992
[TBL] [Abstract][Full Text] [Related]
58. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.
Vesole DH; Pérez WS; Akasheh M; Boudreau C; Reece DE; Bredeson CN;
Mayo Clin Proc; 2006 Jul; 81(7):880-8. PubMed ID: 16835967
[TBL] [Abstract][Full Text] [Related]
59. Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapy.
Sher T; Hayman SR; Gertz MA
Clin Adv Hematol Oncol; 2012 Oct; 10(10):644-51. PubMed ID: 23187770
[TBL] [Abstract][Full Text] [Related]
60. Localized amyloidosis of the tongue: a review.
Fahrner KS; Black CC; Gosselin BJ
Am J Otolaryngol; 2004; 25(3):186-9. PubMed ID: 15124168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
